Stem cells
The main aim of heart group is to differentiate functional cardiomyocytes and hepatocytes from pluripotent stem cells and study different genetic heart diseases and atherosclerosis with the help of induced pluripotent stem cell (iPSC) technology.
Group leader:
Prof. Katriina Aalto-Setälä
https://research.tuni.fi/heart-group/
Cardiac bioelectromechanics and in-silico modelling
Computational Biophysics and Imaging Group (CBIG) is part of Academy of Finland Centre of Excellence on Body on Chip Research.
Group leader:
Prof. Jari Hyttinen
https://research.tuni.fi/cbig/
Clinical Physiology
Research group’s activity focuses on the evaluation of cardiovascular function, hemodynamics and cardiometabolics in health and disease as well as better recognition of high-risk patient.
Group leader:
Prof. Mika Kähönen
https://research.tuni.fi/clinical-physiology
Clinical Research and Medical Biochemistry
Group leader:
Prof. Reijo Laaksonen
Group pages not available
Clinical Research; Cardiothoracic Surgery
Group leader:
Prof. Jari Laurikka
https://research.tuni.fi/cardiac-surgery/
Molecular Biology
Omics and atherosclerosis, Epigenetic inheritance
Group leader:
Prof. Terho Lehtimäki
https://research.tuni.fi/clinical-chemistry/
Molecular Epidemiology
The focus of the study group of Molecular Epidemiology is to investigate the link between molecular phenotypes, such as genetics, epigenetics and gene expression, and the development and onset of common chronic diseases.
Group leader:
Emma Raitoharju
https://www.tuni.fi/en/research/molecular-epidemiology-mole
Medical Biochemistry
We have priority to the Tampere adult population health risk (TAMRISK) material. This has been collected from the year 1980 and it comprises of approx. 40 000-person years of health follow-up, divided to age cohorts.
Group leader:
Prof. Seppo Nikkari
https://www.tuni.fi/en/research/medical-biochemistry
Tampere University Clinical Cardiology Research Group
The clinical cardiology research group is focused on two distinct areas of science: the clinical management of acute atrial tachyarrhythmias and the prediction and prevention of serious adverse events in patients with cardiac diseases.
Group leader:
Prof. Jussi Hernesniemi
Group pages not available
Molecular Biology; Clinical Research
Development of novel, unobtrusive sensor technology for the monitoring of vital signs and diagnostics cardiovascular diseases. Molecular Biology of atherosclerosis.Development of spatial imaging differential ion mobility spectrometry for high throughput analysis of atherosclerotic plaques.
Group leader:
Prof. Niku Oksala
https://www.tuni.fi/en/research/diagnose-extrasensory-olfactory-cues-status-wellbeing-2013-2015
Clinical Research
Group leader:
Prof. Ilkka Pörsti
Group pages not available
Monitoring and measurements
Our main interest is to develop more accurate and well-aimed non-invasive measurements and analysis methods for the detection of cardiopulmonary diseases and wound monitoring.
Group leader:
Prof. Jari Viik
https://research.tuni.fi/physiological-measurement-systems-and-methods/
Sensor Technology and Biomeasurements
Sensor Technology and Biomeasurements Group (STB) focuses on the research and development of embedded measurement technology for physiological monitoring and related signal processing and data analysis methods, mainly in the area of cardiovascular measurements. In addition, we study electronic nose techniques for clinical applications.
Group leader:
Assistant prof. Antti Vehkaoja
https://www.tuni.fi/en/research/sensor-technology-and-biomeasurements